Market
DeepMind spinout Isomorphic Labs raises $2.1 Billion to design drugs with AI
Isomorphic Labs secures $2.1 billion to advance AI-designed drug development, partnering with major pharmaceutical companies for innovative treatments.
Was this article helpful?
Community
Loading comments...


